dPCR Market Size, Share, Trends & Growth 2031

Q: Which region dominated the dPCR market in 2024?

North America dominated the market in 2024... Read more

dPCR Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), End user (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)

Report Date : Jan 2026
Report Code : TIPRE00042218

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 240

The dPCR market size is projected to reach US$ 7.52 billion by 2031 from US$ 14.34 billion in 2024. The market is expected to register a CAGR of 9.9% during 2025–2031.

dPCR Market Analysis

dPCR is gradually taking over the traditional methods of molecular diagnostics by providing direct nucleic acid quantification, not depending on the standard curves, and thus it is more sensitive than qPCR for the detection of rare targets. Its partitioning either by droplets or through the use of a chip allows counting of individual molecules to a very small amount, hence accepting it for the highest accuracy applications such as liquid biopsies in cancer, minimal residual disease monitoring, copy number variation analysis, and pathogen quantification in infectious diseases. Technology is capable of working with very small amounts of mutations, gene fusions, and viral loads, which facilitates the working of companion diagnostics and personalized medicine. The adoption of this technology is rapidly increasing in clinical labs, research institutions, and biopharma research and development, owing to its ability to provide reproducible results even in complex samples. Major companies such as Bio-Rad, QIAGEN, Thermo Fisher, and Stilla Technologies are pushing the envelope through their multiplex capabilities and automation. Other trends that are on the horizon are mixing with NGS workflows, point-of-care adaptations, and AI-based data analysis, and this will keep dPCR as the major player in precision diagnostics of the future when the demand for noninvasive and ultra-sensitive testing solutions is at its peak.

dPCR Market Overview

The dPCR market is moving at a fast pace and creating revolutionary changes in the field of molecular biology. dPCR is already considered the most accurate and sensitive method for quantifying nucleic acids. Conventional PCR methods allow the detection of DNA or RNA only on a relative scale, that is, they need standard curves to indicate the amount of DNA or RNA detected. dPCR does not require such a procedure, and it gives a direct count of the target DNA or RNA molecules. Thus, it is indispensable for applications that demand precise detection of low-abundance genetic targets, rare mutations, or minimal residual disease. Issues of accuracy, reproducibility, sensitivity, and reliability have urged the acceptance of dPCR in varying fields such as clinical diagnostics, oncology, infectious diseases research, and prenatal testing. Furthermore, recent innovations in microfluidics, automation, and multiplexing technologies have been a great help to the market as they have led to an increase in the throughput and ease of use of the dPCR systems. The increased focus on personalized medicine, biomarker discovery, and the early detection of diseases has played a significant role in the widespread interest in dPCR platforms. The major stakeholders, such as research institutions, diagnostic labs, and biotech companies, are developing dPCR applications. Among the regions, developed ones are at the forefront in terms of adoption, whereas emerging markets are quickly growing due to their improving healthcare infrastructure and government support for molecular diagnostics.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

dPCR Market: Strategic Insights

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst

dPCR Market Drivers and Opportunities

Market Drivers:

High Sensitivity and Accuracy: dPCR allows absolute quantification of nucleic acids, detecting low-abundance targets, rare mutations, and minimal residual disease with superior precision compared to conventional PCR methods.
Rising Demand in Clinical Diagnostics: The increasing prevalence of genetic disorders, cancer, and infectious diseases drives the adoption of dPCR in diagnostics, research, and personalized medicine applications worldwide.

Market Opportunities:

Personalized Medicine Applications: dPCR facilitates tailored treatment strategies by analyzing patient-specific genetic profiles, enabling precise therapy selection, monitoring treatment response, and improving clinical outcomes.
Emerging Market Expansion: Growing molecular diagnostics infrastructure, rising healthcare expenditure, and government initiatives in Asia Pacific and Latin America create opportunities for dPCR adoption and market growth.

dPCR Market Report Segmentation Analysis

The dPCR market is divided into different segments to give a clearer view of how it works, its growth potential, and the latest trends. Below is the standard segmentation approach used in industry reports:

By Product:

Reagents & Consumables: The growth of the reagents and consumables segment has been attributed to the repeated requirement to purchase kits and enzymes for dPCR testing due to ongoing illnesses and the continuous need to monitor them.
Instruments: The growth of the instruments segment is attributed to the increase in laboratory automation, surging use of switches to new laboratory systems for older systems, and the growing demand for molecular diagnostics in clinical, research, and public health laboratories.
Software & Services: The growth of the software and service segment has been due to increased demand for analysis and automation of dPCR results, as well as for service support and successful integration of dPCR systems with laboratory information systems.

By Application:

Research Application: The research application segment is growing due to increased use of dPCR in genomics, gene expression studies, biomarker discovery, and academic and pharmaceutical research advancements.
Clinical Application: The clinical application segment is growing due to rising demand for accurate molecular diagnostics in infectious diseases, oncology, genetic testing, and routine hospital laboratory testing worldwide. The clinical application segment is subsegmented as oncology testing, blood screening, infectious disease testing, and other applications.
Forensic Application:
Forensic applications are growing due to the increasing use of dPCR in DNA analysis, crime investigation, human identification, and sensitive detection of biological evidence.

By End User:

Hospitals and Diagnostic Centers
Pharmaceutical and Biotechnology Companies
Research Laboratories and Academic Institutes
Forensic Laboratories
Clinical Research Organizations

By Geography:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Market Report Scope

dPCR Market Share Analysis by Geography

North America leads the global dPCR market, driven by advanced healthcare infrastructure, high investment in research and development, strong demand for molecular diagnostic testing, and the presence of leading biotechnology and diagnostic companies supporting widespread clinical and research adoption.

Europe represents a significant share of the market, supported by well-established healthcare systems, strong emphasis on genetic and infectious disease testing, and extensive utilization of dPCR across academic research, clinical diagnostics, and pharmaceutical development.

Asia Pacific is the fastest-growing market, fueled by expanding healthcare access, increasing demand for advanced molecular diagnostics, rising government healthcare investments, and rapid expansion of laboratory capabilities in countries such as China, India, and Japan.

Latin America and the Middle East & Africa are emerging markets, experiencing growing demand as public health surveillance improves, laboratory infrastructure expands, and awareness of advanced molecular diagnostic technologies increases, although their current market share remains smaller compared to North America, Europe, and Asia Pacific.

Below is a summary of market share and trends by region:

1. North America

Market Share: Holds a significant portion of the global market
Key Drivers:
- Advanced Healthcare and Research Infrastructure
- High Demand for Precision Diagnostics
Trends: Integration of dPCR with Advanced Analytics and Automation

2. Europe

Market Share: Substantial market share
Key Drivers:
- Established Healthcare Systems
- Growing Focus on Genetic and Infectious Disease Testing
Trends: Adoption of Multiplex and High-Throughput dPCR Platforms

3. Asia Pacific

Market Share: Fastest-growing region with a rising market share every year
Key Drivers:
- Expanding Healthcare Infrastructure
- Rising Demand for Molecular Diagnostics
Trends: Government Initiatives and Funding for Genomics and Personalized Medicine

4. South and Central America

Market Share: Growing market with steady progress
Key Drivers:
- Improving Healthcare Infrastructure
- Rising Demand for Infectious Disease and Genetic Testing
Trends: Growing Public Health Surveillance Programs

5. Middle East and Africa

Market Share: Although small, but growing quickly
Key Drivers:
- Expanding Diagnostic Infrastructure
- Increasing Focus on Disease Detection
Trends: Adoption of Automated and Portable dPCR Platforms

dPCR Market Players Density: Understanding Its Impact on Business Dynamics

High Market Density and Competition

Competition is strong due to the presence of established players such as Abbott Laboratories and Takara Bio Inc. Niche providers also contribute to the competitive landscape across regions.

This high level of competition urges companies to stand out by offering:

Advanced Products
Value-added services such as customization and sustainable solutions
Competitive pricing models
Compliance with regulatory guidelines

Opportunities and Strategic Moves

Bio-Rad launched its CFX Opus Deepwell Dx real-time PCR system, an open platform for developing in vitro diagnostic assays. The system multiplexes up to five targets and allows reaction volumes up to 125µL in a 96-well format for quantitative PCR diagnostic assays. CFX Maestro Dx SE software provides data management and analysis tools.
Roche launched a next-generation qPCR system to advance clinical needs in molecular diagnostics and address public health challenges.

Major Companies operating in the dPCR Market are:

Abbott
Qiagen
Bio-Rad Laboratories Inc.
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
GE Healthcare
bioMérieux
F. Hoffmann-La Roche Ltd
Takara Bio Inc
Stilla Technologies

Disclaimer: The companies listed above are not ranked in any particular order.

Other companies analyzed during the course of research:

Fluidigm Corporation (Standard BioTools)
Merck KGaA (Life Science Division)
Promega Corporation
Eppendorf AG
Becton, Dickinson and Company (BD)
Analytik Jena AG
Illumina, Inc.
Sysmex Corporation
Combinati Inc.
Formulatrix, Inc.

dPCR Market News and Recent Developments

Qiagen launches QIAcuityDx dPCR system in January 2025.- Qiagen announced the launch of the QIAcuityDx digital PCR system, an IVD medical device that integrates partitioning, thermocycling, and imaging into a streamlined five-plex workflow. The nanoplate-based workflow disperses a sample into thousands of tiny partitions and then reads reactions simultaneously to quantify signals from DNA and RNA.
Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies in February 2025. - Bio-Rad Laboratories, Inc. (a global leader in life science research and clinical diagnostics products) announced that the company has entered into a binding offer to purchase all equity interests in Stilla Technologies (“Stilla”). The acquisition remains subject to consultation with relevant employee representatives, regulatory approvals, and other customary closing conditions, and is expected to close by the end of the third quarter of 2025.

dPCR Market Report Coverage and Deliverables

The "dPCR Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

dPCR Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
dPCR Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST and SWOT analysis
dPCR Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the dPCR Market
Detailed company profiles

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

This text is related
to segments covered.

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

This text is related
to country scope.

Frequently Asked Questions

What would be the estimated value of the dPCR market by 2031?

The dPCR market is estimated to reach US$ 14.34 billion by 2031.

Which are the leading players operating in the dPCR market?

Abbott Laboratories and Takara Bio Inc are among the key players operating in the dPCR market.

What are the factors driving the dPCR market?

The Increasing demand for highly sensitive and accurate nucleic acid detection, expanding applications in clinical diagnostics and personalized medicine and advancements in dpcr technology and automation are among the noteworthy factors contributing to market growth.

What is the expected CAGR of the dPCR market?

The dPCR market is estimated to register a CAGR of 9.4% during the forecast period.

Which region dominated the dPCR market in 2024?

North America dominated the market in 2024.

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. dPCR Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Global PEST Analysis

5. dPCR Market - Key Industry Dynamics

5.1 Market Drivers

5.1.1 Increasing Demand for Highly Sensitive and Accurate Nucleic Acid Detection

5.1.2 Expanding Applications in Clinical Diagnostics and Personalized Medicine

5.1.3 Rising Advancements in dPCR Technology and Automation

5.2 Market Restraints

5.2.1 High Cost of Instrumentation and Consumables

5.2.2 Lack of Standardization and Regulatory Guidance

5.2.3 Technical Complexity and Need for Specialized Expertise

5.3 Market Opportunities

5.3.1 Growth in Cell & Gene Therapy Quality Control

5.3.2 Expansion into Microbial and Public Health Surveillance

5.3.3 Noninvasive Prenatal Testing (NIPT) and Reproductive Genetics

5.4 Future Trends

5.4.1 Miniaturization and Portability of dPCR Systems

5.4.2 Increased Adoption in Liquid Biopsy for Cancer Diagnostics

5.4.3 Integration with Automation and Bioinformatics for Enhanced Workflow

5.5 Impact Analysis:

6. dPCR Market - Global Market Analysis

6.1 dPCR Market Revenue (US$ Mn), 2021 – 2031

7. Global dPCR Market – Revenue and Forecast to 2031 – by Product

7.1 Overview

7.2 dPCR Market Revenue Share, by Product, 2021 & 2031(%)

7.3 Reagents & Consumables

7.3.1 Overview

7.3.2 Reagents & Consumables: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Instruments

7.4.1 Overview

7.4.2 Instruments: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Software & Services

7.5.1 Overview

7.5.2 Software & Services: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

8. Global dPCR Market – Revenue and Forecast to 2031 – by Application

8.1 Overview

8.2 dPCR Market Revenue Share, by Application, 2021 & 2031(%)

8.3 Research Application

8.3.1 Overview

8.3.2 Research Application: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

8.4 Clinical Application

8.4.1 Overview

8.4.2 Clinical Application: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

8.4.2.1 dPCR Market, by Clinical Application, 2021–2031 (US$ Million)

8.5 Forensic Application

8.5.1 Overview

8.5.2 Forensic Application: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

9. Global dPCR Market – Revenue and Forecast to 2031 – by End-User

9.1 Overview

9.2 dPCR Market Revenue Share, by End-User, 2021 & 2031(%)

9.3 Hospitals and Diagnostic Centers

9.3.1 Overview

9.3.2 Hospitals and Diagnostic Centers: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

9.4 Pharmaceutical and Biotechnology Companies

9.4.1 Overview

9.4.2 Pharmaceutical and Biotechnology Companies: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

9.5 Research Laboratories and Academic Institutes

9.5.1 Overview

9.5.2 Research Laboratories and Academic Institutes: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

9.6 Forensic Laboratories

9.6.1 Overview

9.6.2 Forensic Laboratories: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

9.7 Clinical Research Organizations

9.7.1 Overview

9.7.2 Clinical Research Organizations: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

10. dPCR Market - Geographical Analysis

10.1 North America dPCR Market, Revenue and Forecast To 2031

10.1.1 Overview

10.1.2 North America dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.1.3 North America: dPCR Market, by Product, 2021–2031 (US$ Million)

10.1.4 North America: dPCR Market, by Application, 2021–2031 (US$ Million)

10.1.4.1 North America: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.1.5 North America: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.1.5.1 North America dPCR Market, by Country

10.1.5.2 US

10.1.5.2.1 US dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.1.5.2.2 US: dPCR Market, by Product, 2021–2031 (US$ Million)

10.1.5.2.3 US: dPCR Market, by Application, 2021–2031 (US$ Million)

10.1.5.2.4.1 US: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.1.5.2.5 US: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.1.5.3 Canada

10.1.5.3.1 Canada dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.1.5.3.2 Canada: dPCR Market, by Product, 2021–2031 (US$ Million)

10.1.5.3.3 Canada: dPCR Market, by Application, 2021–2031 (US$ Million)

10.1.5.3.4.1 Canada: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.1.5.3.5 Canada: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.1.5.4 Mexico

10.1.5.4.1 Mexico dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.1.5.4.2 Mexico: dPCR Market, by Product, 2021–2031 (US$ Million)

10.1.5.4.3 Mexico: dPCR Market, by Application, 2021–2031 (US$ Million)

10.1.5.4.3.1 Mexico: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.1.5.4.4 Mexico: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.2 Europe dPCR Market, Revenue and Forecast to 2031

10.2.1 Overview

10.2.2 Europe dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.2.3 Europe: dPCR Market, by Product, 2021–2031 (US$ Million)

10.2.4 Europe: dPCR Market, by Application, 2021–2031 (US$ Million)

10.2.4.1 Europe: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.2.5 Europe: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.2.5.1 Europe dPCR Market, by Country

10.2.5.2 UK

10.2.5.2.1 UK dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.2.5.2.2 UK: dPCR Market, by Product, 2021–2031 (US$ Million)

10.2.5.2.3 UK: dPCR Market, by Application, 2021–2031 (US$ Million)

10.2.5.2.3.1 UK: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.2.5.2.4 UK: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.2.5.3 Germany

10.2.5.3.1 Germany dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.2.5.3.2 Germany: dPCR Market, by Product, 2021–2031 (US$ Million)

10.2.5.3.3 Germany: dPCR Market, by Application, 2021–2031 (US$ Million)

10.2.5.3.3.1 Germany: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.2.5.3.4 Germany: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.2.5.4 France

10.2.5.4.1 France dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.2.5.4.2 France: dPCR Market, by Product, 2021–2031 (US$ Million)

10.2.5.4.3 France: dPCR Market, by Application, 2021–2031 (US$ Million)

10.2.5.4.3.1 France: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.2.5.4.4 France: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.2.5.5 Italy

10.2.5.5.1 Italy dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.2.5.5.2 Italy: dPCR Market, by Product, 2021–2031 (US$ Million)

10.2.5.5.3 Italy: dPCR Market, by Application, 2021–2031 (US$ Million)

10.2.5.5.3.1 Italy: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.2.5.5.4 Italy: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.2.5.6 Spain

10.2.5.6.1 Spain dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.2.5.6.2 Spain: dPCR Market, by Product, 2021–2031 (US$ Million)

10.2.5.6.3 Spain: dPCR Market, by Application, 2021–2031 (US$ Million)

10.2.5.6.3.1 Spain: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.2.5.3.5 Spain: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.2.5.7 Rest of Europe

10.2.5.7.1 Rest of Europe dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.2.5.7.2 Rest of Europe: dPCR Market, by Product, 2021–2031 (US$ Million)

10.2.5.7.3 Rest of Europe: dPCR Market, by Application, 2021–2031 (US$ Million)

10.2.5.7.3.1 Rest of Europe: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.2.5.7.4 Rest of Europe: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.3 Asia Pacific dPCR Market, Revenue and Forecast to 2031

10.3.1 Overview

10.3.2 Asia Pacific dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.3.3 Asia Pacific: dPCR Market, by Product, 2021–2031 (US$ Million)

10.3.4 Asia Pacific: dPCR Market, by Application, 2021–2031 (US$ Million)

10.3.4.1 Asia Pacific: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.3.5 Asia Pacific: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.3.5.1 Asia Pacific dPCR Market, by Country

10.3.5.2 China

10.3.5.2.1 China dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.3.5.2.2 China: dPCR Market, by Product, 2021–2031 (US$ Million)

10.3.5.2.3 China: dPCR Market, by Application, 2021–2031 (US$ Million)

10.3.5.2.3.1 China: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.3.5.2.4 China: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.3.5.3 Japan

10.3.5.3.1 Japan dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.3.5.3.2 Japan: dPCR Market, by Product, 2021–2031 (US$ Million)

10.3.5.3.3 Japan: dPCR Market, by Application, 2021–2031 (US$ Million)

10.3.5.3.3.1 Japan: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.3.5.3.4 Japan: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.3.5.4 India

10.3.5.4.1 India dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.3.5.4.2 India: dPCR Market, by Product, 2021–2031 (US$ Million)

10.3.5.4.3 India: dPCR Market, by Application, 2021–2031 (US$ Million)

10.3.5.4.3.1 India: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.3.5.4.4 India: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.3.5.5 Australia

10.3.5.5.1 Australia dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.3.5.5.2 Australia: dPCR Market, by Product, 2021–2031 (US$ Million)

10.3.5.5.3 Australia: dPCR Market, by Application, 2021–2031 (US$ Million)

10.3.5.5.3.1 Australia: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.3.5.5.4 Australia: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.3.5.6 South Korea

10.3.5.6.1 South Korea dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.3.5.6.2 South Korea: dPCR Market, by Product, 2021–2031 (US$ Million)

10.3.5.6.3 South Korea: dPCR Market, by Application, 2021–2031 (US$ Million)

10.3.5.6.3.1 South Korea: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.3.5.6.4 South Korea: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.3.5.7 Rest of Asia Pacific

10.3.5.7.1 Rest of Asia Pacific dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.3.5.7.2 Rest of Asia Pacific: dPCR Market, by Product, 2021–2031 (US$ Million)

10.3.5.7.3 Rest of Asia Pacific: dPCR Market, by Application, 2021–2031 (US$ Million)

10.3.5.7.3.1 Rest of Asia Pacific: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.3.5.7.4 Rest of Asia Pacific: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.4 Middle East & Africa dPCR Market, Revenue and Forecast to 2031

10.4.1 Overview

10.4.2 Middle East & Africa dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.4.3 Middle East & Africa: dPCR Market, by Product, 2021–2031 (US$ Million)

10.4.4 Middle East & Africa: dPCR Market, by Application, 2021–2031 (US$ Million)

10.4.4.1 Middle East & Africa: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.4.5 Middle East & Africa: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.3.5.1 Middle East & Africa dPCR Market, by Country

10.3.5.2 Saudi Arabia

10.3.5.2.1 Saudi Arabia dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.3.5.2.2 Saudi Arabia: dPCR Market, by Product, 2021–2031 (US$ Million)

10.3.5.2.3 Saudi Arabia: dPCR Market, by Application, 2021–2031 (US$ Million)

10.3.5.2.3.1 Saudi Arabia: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.3.5.2.4 Saudi Arabia: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.3.5.3 UAE

10.3.5.3.1 UAE dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.3.5.3.2 UAE: dPCR Market, by Product, 2021–2031 (US$ Million)

10.3.5.3.3 UAE: dPCR Market, by Application, 2021–2031 (US$ Million)

10.3.5.3.3.1 UAE: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.3.5.3.5 UAE: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.3.5.4 South Africa

10.3.5.4.1 South Africa dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.3.5.4.2 South Africa: dPCR Market, by Product, 2021–2031 (US$ Million)

10.3.5.4.3 South Africa: dPCR Market, by Application, 2021–2031 (US$ Million)

10.3.5.4.3.1 South Africa: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.3.5.4.4 South Africa: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.3.5.5 Rest of Middle East & Africa

10.3.5.5.1 Rest of Middle East & Africa dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.3.5.5.2 Rest of Middle East & Africa: dPCR Market, by Product, 2021–2031 (US$ Million)

10.3.5.5.3 Rest of Middle East & Africa: dPCR Market, by Application, 2021–2031 (US$ Million)

10.3.5.5.3.1 Rest of Middle East & Africa: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.3.5.5.4 Rest of Middle East & Africa: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.5 South & Central America dPCR Market, Revenue and Forecast to 2031

10.5.1 Overview

10.5.2 South & Central America dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.5.3 South & Central America: dPCR Market, by Product, 2021–2031 (US$ Million)

10.5.4 South & Central America: dPCR Market, by Application, 2021–2031 (US$ Million)

10.5.4.1 South & Central America: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.5.5 South & Central America: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.5.5.1 South & Central America dPCR Market, by Country

10.5.5.2 Brazil

10.5.5.2.1 Brazil dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.5.5.2.2 Brazil: dPCR Market, by Product, 2021–2031 (US$ Million)

10.5.5.2.3 Brazil: dPCR Market, by Application, 2021–2031 (US$ Million)

10.5.5.2.3.1 Brazil: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.5.5.2.4 Brazil: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.5.5.3 Argentina

10.5.5.3.1 Argentina dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.5.5.3.2 Argentina: dPCR Market, by Product, 2021–2031 (US$ Million)

10.5.5.3.3 Argentina: dPCR Market, by Application, 2021–2031 (US$ Million)

10.5.5.3.3.1 Argentina: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.5.5.3.4 Argentina: dPCR Market, by End-User, 2021–2031 (US$ Million)

10.5.5.4 Rest of South & Central America

10.5.5.4.1 Rest of South & Central America dPCR Market Revenue and Forecast to 2031 (US$ Mn)

10.5.5.4.2 Rest of South & Central America: dPCR Market, by Product, 2021–2031 (US$ Million)

10.5.5.4.3 Rest of South & Central America: dPCR Market, by Application, 2021–2031 (US$ Million)

10.5.5.4.3.1 Rest of South & Central America: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)

10.5.5.4.4 Rest of South & Central America: dPCR Market, by End-User, 2021–2031 (US$ Million)

11. dPCR Market–Industry Landscape

11.1 Overview

11.2 Growth Strategies in dPCR Market

11.3 Organic Growth Strategies

11.3.1 Overview

11.4 Inorganic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Sysmex Inostics Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Thermo Fisher Scientific Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Takara Bio Inc

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Qiagen NV

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Stilla Technologies

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 bioMerieux SALtd

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 F. Hoffmann-La Roche Ltd

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Bio-Rad Laboratories Inc

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Agilent Technologies Inc

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Standard BioTools Inc

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 SWOT Analysis

12.10.5 Key Developments

13. Appendix

13.1 About Us

13.2 Glossary of Terms

List of Tables

Table 1. dPCR Market Segmentation

Table 2. dPCR Market, by Clinical Application – Revenue and Forecast to 2031 (US$ Million)

Table 3. North America dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 4. North America dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 5. North America dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 6. North America dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 7. US dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 8. US dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 9. US dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 10. US dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 11. Canada dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 12. Canada dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 13. Canada dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 14. Canada dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 15. Mexico dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 16. Mexico dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 17. Mexico dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 18. Mexico dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 19. Europe dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 20. Europe dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 21. Europe dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 22. Europe dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 23. UK dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 24. UK dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 25. UK dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 26. UK dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 27. Germany dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 28. Germany dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 29. Germany dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 30. Germany dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 31. France dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 32. France dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 33. France dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 34. France dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 35. Italy dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 36. Italy dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 37. Italy dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 38. Italy dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 39. Spain dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 40. Spain dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 41. Spain dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 42. Spain dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 43. Rest of Europe dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 44. Rest of Europe dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 45. Rest of Europe dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 46. Rest of Europe dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 47. Asia Pacific dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 48. Asia Pacific dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 49. Asia Pacific dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 50. Asia Pacific dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 51. China dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 52. China dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 53. China dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 54. China dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 55. Japan dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 56. Japan dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 57. Japan dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 58. Japan dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 59. India dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 60. India dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 61. India dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 62. India dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 63. Australia dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 64. Australia dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 65. Australia dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 66. Australia dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 67. South Korea dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 68. South Korea dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 69. South Korea dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 70. South Korea dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 71. Rest of Asia Pacific dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 72. Rest of Asia Pacific dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 73. Rest of Asia Pacific dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 74. Rest of Asia Pacific dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 75. Middle East & Africa dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 76. Middle East & Africa dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 77. Middle East & Africa dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 78. Middle East & Africa dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 79. Saudi Arabia dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 80. Saudi Arabia dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 81. Saudi Arabia dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 82. Saudi Arabia dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 83. UAE dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 84. UAE dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 85. UAE dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 86. UAE dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 87. South Africa dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 88. South Africa dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 89. South Africa dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 90. South Africa dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 91. Rest of Middle East & Africa dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 92. Rest of Middle East & Africa dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 93. Rest of Middle East & Africa dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 94. Rest of Middle East & Africa dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 95. South & Central America dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 96. South & Central America dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 97. South & Central America dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 98. South & Central America dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 99. Brazil dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 91. Brazil dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 92. Brazil dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 93. Brazil dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 94. Argentina dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 95. Argentina dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 96. Argentina dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 97. Argentina dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 98. Rest of South & Central America dPCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)

Table 99. Rest of South & Central America dPCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)

Table 100. Rest of South & Central America dPCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)

Table 101. Rest of South & Central America dPCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)

Table 102. Recent Organic Growth Strategies in dPCR Market

Table 103. Recent Inorganic Growth Strategies in the dPCR Market

Table 104. Glossary of Terms, dPCR Market

List of Figures

Figure 1. dPCR Market Segmentation, By Geography

Figure 2. Global - PEST Analysis

Figure 3. dPCR Market - Key Industry Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. dPCR Market Revenue (US$ Mn), 2021 – 2031

Figure 6. dPCR Market Revenue, Geography (US$ Mn), 2021 – 2031

Figure 7. Quantitative PCR: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8. Digital PCR: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

Figure 9. dPCR Market Revenue Share, by Product, 2021 & 2031(%)

Figure 10. Reagents & Consumables: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

Figure 11. Instruments: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

Figure 12. Software & Services: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

Figure 13. dPCR Market Revenue Share, by Application, 2021 & 2031(%)

Figure 14. Research Application: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

Figure 15. Clinical Application: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

Figure 16. Forensic Application: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

Figure 17. dPCR Market Revenue Share, by End-User, 2021 & 2031(%)

Figure 18. Hospitals and Diagnostic Centers: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

Figure 19. Pharmaceutical and Biotechnology Companies: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

Figure 20. Research Laboratories and Academic Institutes: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

Figure 21. Forensic Laboratories: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

Figure 22. Clinical Research Organizations: dPCR Market – Revenue and Forecast to 2031 (US$ Million)

Figure 23. North America: dPCR Market, by Key Country – Revenue (2022) (US$ Million)

Figure 24. North America dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 25. North America dPCR Market, By Key Countries, 2022 and 2031 (%)

Figure 26. US dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 27. Canada dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 28. Mexico dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 29. Europe dPCR Market, by Key Country – Revenue, 2022 (US$ Million)

Figure 30. Europe dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 31. Europe dPCR Market, By Key Countries, 2022 and 2031 (%)

Figure 32. UK dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 33. Germany dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 34. France dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 35. Italy dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 36. Spain dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 37. Rest of Europe dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 38. Asia Pacific dPCR Market, by Key Country – Revenue, 2022 (US$ Million)

Figure 39. Asia Pacific dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 40. Asia Pacific dPCR Market, By Key Countries, 2022 and 2031 (%)

Figure 41. China dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 42. Japan dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 43. India dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 44. Australia dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 45. South Korea dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 46. Rest of Asia Pacific dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 47. Middle East & Africa dPCR Market, by Key Country – Revenue, 2022 (US$ Million)

Figure 48. Middle East & Africa dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 49. Middle East & Africa dPCR Market, By Key Countries, 2022 and 2031 (%)

Figure 50. Saudi Arabia dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 51. UAE dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 52. South Africa dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 53. Rest of Middle East & Africa dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 54. South & Central America dPCR Market, by Key Country – Revenue, 2022 (US$ Million)

Figure 55. South & Central America dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 56. South & Central America dPCR Market, By Key Countries, 2022 and 2031 (%)

Figure 57. Brazil dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 58. Argentina dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 59. Rest of South & Central America dPCR Market Revenue and Forecast to 2031 (US$ Mn)

Figure 60. Growth Strategies in dPCR Market

Your Key Concerns Addressed - Question & Answer

Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.

Is there support available if I can't access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
Validates and strengthens in-house secondary research findings
Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

Industry participants: VPs, business development managers, market intelligence managers and national sales managers
Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.